IMV : Dr. Graff will lead IMV's research to continue the expansion of DPX- based immuno-oncology pipelineand the development of a comprehensive translational strategy to optimize clinical success (Form 6-K)
Dr. Graff will lead IMV's research to continue the expansion of DPX- based immuno-oncology pipeline and the development of a comprehensive translational strategy to optimize... | June 9, 2021